Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelfinavir with Concurrent Thoracic Chemoradiotherapy in Locally-Advanced NSCLC
NCT00589056Phase 2Completed
- Sponsor
- Abramson Cancer Center
- Start
- Jun 2007
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nelfinavir in non-small cell lung cancer (NSCLC), sponsored by Abramson Cancer Center. Started Jun 2007; status: completed.
02
Drugs
nelfinavir
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00589056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589056.